Breaking News, Collaborations & Alliances

Zebra Biologics, AbbVie Form Pact

Collaboration set up to discover new antibody therapeutics

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Emerging biotech Zebra Biologics has entered into a collaboration with AbbVie to discover agonist antibody therapeutics for inflammatory diseases. Zebra will use its novel and patented function-based antibody discovery platform to generate antibodies that activate biological pathways associated with targets designated by AbbVie. Zebra and AbbVie will collaborate closely on the identification and pre-clinical validation of candidates. AbbVie would then be responsible for clinical development, manufacturing, regulatory approval and worldwide commercialization.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters